Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
$1.99
per week
for 24 weeks
// //

Recent reports of heart inflammation in young men after mRNA COVID-19 vaccinations may have some parents and youth considering how – or whether – to proceed with getting their shot.

These cases, though rare, present a new complication for those who are weighing the potential risks of vaccine side effects against the risk of contracting COVID-19. Meanwhile, the drive to get as many Canadians, including young people, fully vaccinated has become all the more urgent as the threat of a highly infectious Delta variant grows.

The Globe asked experts to explain the issue and provide guidance.

Story continues below advertisement

What is the concern?

Officials in the U.S. and Israel have reported cases of myocarditis and pericarditis, particularly among young men around age 16 to 24, following a second dose of mRNA vaccines, which are produced by Pfizer or Moderna. Myocarditis is an inflammation of the heart muscle, and pericarditis is an inflammation of the lining outside the heart.

But it’s still unclear whether these conditions are related to the vaccine, or a coincidence.

The U.S. Centres for Disease Control and Prevention (CDC) is scheduled to discuss this matter in a meeting June 18.

Meanwhile in Canada, health officials have said the number of cases of these conditions after vaccination has been small. Health Canada and the Public Health Agency of Canada say they are monitoring reports of cases. And health authorities continue to encourage people to get immunized as soon as possible.

To ensure stronger protection against variants of concern, including the highly infectious Delta variant, “those who are eligible are urged to get fully vaccinated, including getting the second dose of a two-dose COVID-19 vaccine series,” Canada’s Chief Public Health Officer, Theresa Tam, said in a statement Wednesday.

Coronavirus tracker: How many COVID-19 cases are there in Canada and worldwide? The latest maps and charts

How many cases have been reported in Canada?

Very few so far. According to the latest national data, there were 35 reported cases of myocarditis and pericarditis following a COVID-19 vaccination in the country, up to and including June 4.

Unlike international reports, the cases in Canada have been fairly evenly split between men and women, with 19 females and 16 males, and the median age was 51 years for women and 40 years for men. Also unlike reports in the U.S. and Israel where these conditions appeared higher after the second dose, Canadian data showed 22 reported cases were after a first dose of vaccine and 11 were after the second dose. (The dose for the other two cases was not specified.)

Story continues below advertisement

In a more recent report, Public Health Ontario’s summary of adverse health incidents following immunization showed there were three cases in people under 18 in the province as of June 5.

How serious are myocarditis and pericarditis?

Generally, pericarditis is fairly benign, while myocarditis is a more serious condition, said Gavin Oudit, a professor in the department of medicine at the University of Alberta and clinician-scientist at the Mazankowski Alberta Heart Institute.

“But they typically happen all the time, and it’s often seasonal,” Dr. Oudit said, explaining the conditions can be caused by many different kinds of viruses, including seasonal ones.

Almost all of the cases reported after COVID-19 vaccination have been mild, and most have resolved on their own, or after treatment with anti-inflammatory medications or steroids, Dr. Oudit said.

In the CDC data, 81 per cent of the 221 patients whose recovery status was known recovered fully from their symptoms. The other 19 per cent included patients with ongoing signs or symptoms.

Why do these cases seem to be more prevalent among young men?

Experts don’t yet know. Nor are there any definitive answers yet as to why the cases are higher after a second dose.

Story continues below advertisement

It might be a reflection of a general pattern, since myocarditis generally seems to be more common in younger age groups and in males, said Karina Top, a pediatric infectious-disease specialist at the IWK Health Centre in Halifax and investigator at the Canadian Center for Vaccinology.

Young people tend to have a stronger immune response than older age groups, Dr. Oudit noted. And women tend to have a different immune response to viral infections than men, which may explain why these cases are higher in young men, he said.

Waiting for a second shot? Here’s what you need to know

What are the signs to look out for?

In reports from the U.S. and Israel, people have been developing symptoms such as shortness of breath, chest pain, cough, and in more severe cases, swelling in the ankles and feet, Dr. Top said, adding some may also feel light-headed. These symptoms typically start within a few days of getting a second vaccine dose.

Even though it’s the more benign of the two, pericarditis can cause worse symptoms than myocarditis, since the pericardium – or lining around the heart – has a lot of nerves, so it can be very painful, Dr. Oudit said. But it generally clears up within a week or so, he said. With both conditions, people can also experience fatigue, fever and muscle aches, he added.

While Dr. Top recommended getting checked out by a health professional if you experience any of these symptoms, Dr. Oudit suggested taking a non-steroidal anti-inflammatory drug such as ibuprofen if you don’t feel too bad and the symptoms aren’t severe. If symptoms persist for more than three or four days, however, or you start having other problems – such as worsening shortness of breath, extreme fatigue or an abnormal pulse – see your family physician, he advised.

So what should parents and young people do about second doses?

While it’s understandable these cases of myocarditis and pericarditis have sparked concern, the fact that officials have picked up on them and are responding to them is a good thing, Dr. Top said.

Story continues below advertisement

It’s “a sign our systems we have in place around vaccine safety are working,” she said.

It’s also important to note that COVID-19 itself has been shown to cause myocarditis in rare instances in young people, and it is also associated with multisystem inflammatory syndrome, which can involve severe inflammation of the heart and the blood vessels in the heart, she said.

Given the risks of COVID-19, and the mild nature of rare cases of myocarditis and pericarditis after vaccination, Dr. Top said it’s still recommended that young people get fully vaccinated.

“The benefits still outweigh the risks at this point in time,” she said.

According to government data, people under age 30 now account for a growing share of COVID-19 cases. Those under 19 years old make up 19 per cent of all COVID-19 cases reported as of June 11 since the start of the pandemic, tied with 20- to 29-year-olds.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies